Vyleesi Approved for Women with Low Libido
Premenopausal women who suffer from hypoactive sexual desire disorder (HSDD) might have a new treatment option later this year.
The injectable drug Vyleesi was approved by the U.S. Food and Drug Administration (FDA) last month. It is intended for women with certain forms of HSDD, a disorder marked by low interest in sex that causes distress.
More details about Vyleesi, including clinical trial results and safety information, can be found here.
How Might Marijuana Affect Sperm Cells?
Over the past few years, recreational marijuana use has become legal in communities across North America. But we still have much to learn about weed's effects on our general health.
That goes for sexual and reproductive health too. Past studies have suggested that marijuana could impair sperm cells, making it more difficult for them to fertilize an egg.
Does this thinking still hold? Our latest blog post looks at two studies concerning marijuana and male fertility that were published earlier this year.
What should hopeful parents know? Find out here.
|
